Wells Fargo & Company Clear Point Neuro, Inc. Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 69 shares of CLPT stock, worth $1,253. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69
Previous 25
176.0%
Holding current value
$1,253
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CLPT
# of Institutions
86Shares Held
6.64MCall Options Held
84.3KPut Options Held
56.7K-
Vanguard Group Inc Valley Forge, PA1.24MShares$22.6 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA409KShares$7.42 Million1.22% of portfolio
-
Black Rock Inc. New York, NY366KShares$6.65 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$6.05 Million0.0% of portfolio
-
Cm Management, LLC290KShares$5.27 Million4.19% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $445M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...